Back

JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Genetics in cardiomyopathies Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Juha Koskenvuo

Turku University Hospital, Turku (Finland)

13 More presentations in this session

Presentation thumbnail
FHOD3 is a novel disease causing gene in hypertrophic cardiomyopathy
Doctor J. Ochoa (A Coruna, ES)
Abstract Slides
Presentation thumbnail
Clinical presentation and outcomes in paediatric-onset hypertrophic cardiomyopathy associated with MYBPC3 mutations
Miss E. Field (London, GB)
Abstract Slides
Presentation thumbnail
Genotype phenotype relation in patients with hypertrophic cardiomyopathy: development of a model to predict the genetic yield
Doctor T. Robyns (Leuven, BE)
Abstract
Presentation thumbnail
Next generation sequencing in patients with hypertrophic cardiomyopathy
Associate Professor J. Bonaventura (Prague, CZ)
Abstract
Presentation thumbnail
Genetic spectrum of hypertrophic cardiomyopathy revisited. Whole Exome Sequencing reveals extreme genetic heterogeneity and new gene mutations in a multicenter series of 200 patients
Doctor K. Nguyen (Marseille, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Genetics in cardiomyopathies

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources